Top compounds associated with response to RP13-210D15.9


Feature Type Standardized
Nominal ANOVA
mRNA ML006 CTRPv2 pan-cancer AAC -0.0086 0.8
mRNA SGX-523 CTRPv2 pan-cancer AAC 0.0086 0.8
mRNA JW-74 CTRPv2 pan-cancer AAC 0.011 0.8
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0074 0.8
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0082 0.8
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.0084 0.8
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.0082 0.8
mRNA BMS-195614 CTRPv2 pan-cancer AAC -0.0084 0.8
mRNA Ki8751 CTRPv2 pan-cancer AAC -0.0079 0.8
mRNA BRD-K86535717 CTRPv2 pan-cancer AAC -0.016 0.8
Download CSV